Pure Global
NCT06213805

Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma Surgery

Hôpital Privé de la Baie·ClinicalTrials.gov·procedureNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Glaucoma
Drug/Device/Intervention
Minimally invasive microsclerostomy
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Hôpital Privé de la Baie
Timeline & enrollment
Phase
N/A
Start date
Jan 15, 2024
End date
Feb 28, 2026
Enrollment
23 participants
Primary outcome

Measurement of intraocular pressure by tonometry

Summary

The main objective is to evaluate the effectiveness of MIMS in patients with an indication
 for glaucoma surgery, compared to traditional surgery. The secondary objective is to assess
 safety. The investigating ophthalmologist will follow the patients and collect clinical data
 in order to identify the benefits and complications of MIMS. Patients are expected to
 experience fewer complications compared to traditional glaucoma surgery.

ICD-10 classifications
GlaucomaGlaucomaOther glaucomaGlaucoma, unspecifiedGlaucoma in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06213805
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06213805 through Pure Global AI's free database. This phase not specified trial is sponsored by Hôpital Privé de la Baie and is currently Not yet recruiting. The study focuses on Glaucoma. Target enrollment is 23 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.